Suppr超能文献

ALOX5AP 基因启动子区遗传变异与缺血性脑卒中易感性。

Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke.

机构信息

Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China.

出版信息

Cerebrovasc Dis. 2011;32(3):261-8. doi: 10.1159/000330341. Epub 2011 Aug 31.

Abstract

BACKGROUND

Despite accumulating evidence supporting the association between variants of the ALOX5AP gene and atherosclerotic vascular events, the precise mechanism is still unclear. No variants in the coding sequence that lead to amino acid substitution have been found. We investigated genetic variants in the promoter region of the ALOX5AP gene and the association with ischemic stroke in a north Chinese Han population.

METHODS

505 cases of ischemic stroke and 500 age- and gender-matched controls of the north Chinese Han population were enrolled. Genetic variants in the promoter region of the ALOX5AP gene were identified by polymerase chain reaction and DNA sequencing. 40 cases and 40 controls were randomly selected and compared for serum leukotriene B(4) (LTB(4)) concentration. The effect on ischemic stroke was evaluated by logistic regression.

RESULTS

Three genetic variants were identified, including a mutation (-519 G > A), an insertion and deletion polymorphisms (-581_582 Ins A) and a single nuclear polymorphisms (-946 A > G). Association study showed that the II genotype of -581_582 Ins A was significantly associated with ischemic stroke of a large artery atherosclerosis (OR = 3.50, 95% CI = 1.93-6.36, p = 0.0002) and undetermined etiology (OR = 3.66, 95% CI = 1.92-6.94, p = 0.0006). No significant association was found between the -519 GA genotype (OR = 0.35, 95% CI = 0.02-5.88, p = 0.46), -946 AG genotype (OR = 1.35, 95% CI = 0.85-2.16, p = 0.21) and ischemic stroke. There was no significant difference in serum LTB(4) concentration between cases (n = 40) and controls (n = 40) (log serum LTB(4) of cases vs. controls: 2.67 ± 0.14 vs. 2.73 ± 0.18 pg/ml, p = 0.10). However, the serum LTB(4) concentration was significantly higher in participants with the II genotype of -581_582 Ins A (n = 12) than that of participants with the DD genotype (n = 68) (log serum LTB(4) of participants with II genotype vs. DD genotype: 2.82 ± 0.18 vs. 2.68 ± 0.15 pg/ml, p = 0.01).

CONCLUSION

The -581_582 Ins A polymorphism might be a novel genetic risk factor for ischemic stroke in a north Chinese Han population. Further studies on molecular mechanism are warranted.

摘要

背景

尽管有越来越多的证据支持 ALOX5AP 基因变异与动脉粥样硬化血管事件之间的关联,但确切的机制仍不清楚。尚未发现导致氨基酸替换的编码序列中的变异。我们研究了中国北方汉族人群 ALOX5AP 基因启动子区域的遗传变异与缺血性中风的关系。

方法

纳入了 505 例缺血性中风患者和 500 例年龄和性别匹配的中国北方汉族对照组。通过聚合酶链反应和 DNA 测序鉴定 ALOX5AP 基因启动子区域的遗传变异。随机选择 40 例病例和 40 例对照比较血清白三烯 B4(LTB4)浓度。通过 logistic 回归评估对缺血性中风的影响。

结果

鉴定出 3 种遗传变异,包括突变(-519 G > A)、插入缺失多态性(-581_582InsA)和单核苷酸多态性(-946A > G)。关联研究表明,-581_582InsA 的 II 基因型与大动脉粥样硬化性缺血性中风(OR=3.50,95%CI=1.93-6.36,p=0.0002)和不明病因(OR=3.66,95%CI=1.92-6.94,p=0.0006)显著相关。-519GA 基因型(OR=0.35,95%CI=0.02-5.88,p=0.46)、-946AG 基因型(OR=1.35,95%CI=0.85-2.16,p=0.21)与缺血性中风无显著相关性。病例(n=40)和对照组(n=40)之间的血清 LTB4 浓度无显著差异(病例的 log 血清 LTB4 与对照组:2.67±0.14 vs. 2.73±0.18pg/ml,p=0.10)。然而,-581_582InsA 的 II 基因型(n=12)参与者的血清 LTB4 浓度明显高于 DD 基因型(n=68)参与者(II 基因型与 DD 基因型参与者的 log 血清 LTB4:2.82±0.18 vs. 2.68±0.15pg/ml,p=0.01)。

结论

-581_582InsA 多态性可能是中国北方汉族人群缺血性中风的一个新的遗传危险因素。需要进一步研究其分子机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验